Georgii P Georgiev

Title: Georgii P Georgiev: Innovator in Cancer Research

Introduction

Georgii P Georgiev is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of cancer research, particularly in the identification of genes that inhibit tumor growth and induce apoptosis in cancer cells. With a total of 2 patents, his work is paving the way for advancements in cancer therapy.

Latest Patents

Georgiev's latest patents include groundbreaking inventions related to tumor growth inhibition and apoptosis-associated genes and polypeptides. One of his notable inventions focuses on the identification of mouse and human genes that inhibit tumor growth and induce apoptosis in cancer cells. This invention specifically concerns the nucleotide sequence of a tumor-inhibiting gene known as tag7, along with the amino acid sequence of the polypeptide encoded by tag7. The patent also provides isolated nucleic acid molecules comprising tag7 polynucleotides, as well as methods for producing tag7 polypeptides and antibodies that specifically bind to the tag7 polypeptide. These innovations are crucial for developing methods of cancer therapy using tag7 nucleic acid molecules and polypeptides.

Career Highlights

Georgii P Georgiev is currently associated with Boehringer Ingelheim International GmbH, where he continues to contribute to innovative research in the pharmaceutical industry. His work is instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.

Collaborations

Georgiev has collaborated with notable colleagues such as Sergei L Kiselev and Egor B Prokhorchouk. These collaborations enhance the research efforts in the field of cancer therapy and contribute to the overall success of their projects.

Conclusion

Georgii P Georgiev is a distinguished inventor whose work in cancer research is making a significant impact. His innovative patents and collaborations are paving the way for new therapeutic approaches in the fight against cancer.